NCT05387993

Brief Summary

The aim of the study was to identify the incidence of infective keratitis presenting to the ophthalmology emergency department at Cairo University hospital, the risk factors and the bacterial/fungal spectrum causing the ulcers and to determine the best possible empirical therapy followed by specific therapy after obtaining culture results.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2021

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2021

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 17, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 24, 2022

Completed
Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

9 months

First QC Date

May 17, 2022

Last Update Submit

May 20, 2022

Conditions

Keywords

Corneal ulcerMicrobiological profileFungal keratitisBacterial keratitisInfective keratitisAntimicrobial susceptibility

Outcome Measures

Primary Outcomes (3)

  • To identify risk factors and the most common causative organisms of microbial keratitis among the Egyptian population through history taking from each patient and the results of corneal sampling taken from the ulcer.

    Thorough history taking including risk factors that contributed to the ulcer occurrence. Corneal sampling through corneal scraping from the base and edge of the ulcer that undergoes direct examination and culturing using standard laboratory protocols.

    Three weeks for each participant

  • To detect incidence of infective keratitis amongst all ophthalmological casualty cases by documenting the number of cases presenting or referred to the casualty of the ophthalmology department.

    Noting down the number of patients diagnosed with microbial keratitis that present to the casualty of a tertiary referral hospital, and calculate the percentage amongst all other ophthalmic casualty cases that present to the emergency as well.

    through study completion, an average of eight months

  • To detect antimicrobial susceptibility and resistance of different antimicrobial agents causing corneal infections in our study group.

    Antibiotic susceptibility testing was performed by the disc diffusion method (Modified Kirby Bauer technique) using Muller Hinton agar, aerobic incubation at 35°C for 16-18 hours. Anti fungal susceptibility was done using microdilution testing following the CLSI reference method.

    two weeks for each participant

Secondary Outcomes (2)

  • To assess the impact of culture and sensitivity results of corneal scrapings on the initial empirical therapy by calculating the number of cases that needed to shift the initial therapy to another one according to the antimicrobial susceptibility.

    six months

  • Improving lines of management of microbial keratitis for a better outcome based on the cooperation between clinical ophthalmologists and microbiologists to reach a proper diagnosis and tailor the management accordingly.

    six months

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Recruitment occurred from the Ophthalmology outpatient clinics and casualty department in Cairo University Hospitals, Kasr Al Aini. They met all inclusion and exclusion criteria for enrollment into this study.

You may qualify if:

  • Patients presenting at the casualty who are clinically diagnosed as infectious keratitis , of all age groups and including both genders.

You may not qualify if:

  • Patients presenting with clinical picture suggestive of
  • Viral keratitis solely without superimposed secondary infection.
  • Non infectious keratitis as peripheral ulcerative keratitis ( e.g. Mooren's ulcer, marginal keratitis, autoimmune keratitis )

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Al Aini Hospital

Cairo, 11562, Egypt

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Corneal scrapings from cornea of infected eyes.

MeSH Terms

Conditions

Corneal Ulcer

Condition Hierarchy (Ancestors)

Eye InfectionsInfectionsKeratitisCorneal DiseasesEye Diseases

Study Officials

  • Yehia Mostafa, MD

    Kasr Al Aini Hospital

    STUDY CHAIR
  • Mohamed El Agha, MD

    Kasr Al Aini Hospital

    STUDY DIRECTOR
  • Ihab Othman, MD

    Kasr Al Aini Hospital

    STUDY DIRECTOR
  • Moushira Hosny, MD

    Kasr Al Aini Hospital

    STUDY DIRECTOR
  • Nevien Lotfy, MSc

    Kasr Al Aini Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophthalmology Resident at the Ophthalmology Department, Cairo University.

Study Record Dates

First Submitted

May 17, 2022

First Posted

May 24, 2022

Study Start

September 10, 2020

Primary Completion

May 30, 2021

Study Completion

June 15, 2021

Last Updated

May 24, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL
Time Frame
After being published.

Locations